ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
Ito
Y
Y
Shimamoto
T
T
Kuriyama
Y
Y
Nakajima
A
A
Sumi
M
M
Watanabe
Y
Y
Beppu
H
H
Ohtsubo
K
K
Ohyashiki
K
K
D002890:Chromosomes, Human, Pair 20; D002892:Chromosomes, Human, Pair 22; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000032:analysis; D015321:Gene Rearrangement; D016313:Genes, abl; D006801:Humans; D007621:Karyotyping; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000209:etiology / Q000235:genetics*; D054438:Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / Q000175:diagnosis / Q000209:etiology / Q000235:genetics*; D008875:Middle Aged; D015513:Oncogene Proteins / Q000235:genetics*; D011505:Protein-Tyrosine Kinases; D011518:Proto-Oncogene Proteins; D051562:Proto-Oncogene Proteins c-bcr; D014178:Translocation, Genetic
D015513:Oncogene Proteins; D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; D016044:Fusion Proteins, bcr-abl; C496613:BCR protein, human; D051562:Proto-Oncogene Proteins c-bcr